MiNK Therapeutics ( (INKT)) has issued an announcement. MiNK Therapeutics Inc. has appointed Dr. Robert Kadlec as a Class II director on its Board, with a term lasting until 2026. Dr. Kadlec’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback